```html

Rash on Palms and Soles

What is Rash on palms and soles?

A rash that appears on the palms of the hands or the soles of the feet is a visible change in skin color, texture, or appearance that can range from a few tiny spots to widespread redness, scaling, or blistering. Because the skin on the palms and soles is thicker and has a different distribution of sweat glands compared to other body areas, rashes in these locations often point to specific underlying conditions. Recognizing the pattern, timing, and accompanying symptoms helps providers narrow the cause and decide on the best management plan.

Common Causes

Several diseases and external factors can produce a rash on the palms and/or soles. The most frequent culprits include:

• Hand‑foot‑mouth disease – A viral infection (usually coxsackievirus A16 or enterovirus 71) common in children. The rash is often vesicular and may be accompanied by oral sores.
• Palmoplantar psoriasis – A chronic autoimmune skin disorder that causes well‑demarcated, thick, red plaques with silvery scales.
• Syphilis (secondary stage) – The “palmar rash” of secondary syphilis is classically symmetric, non‑pruritic, and may have a coppery hue.
• Fungal infections (tinea manuum / tinea pedis) – Dermatophytes can lead to scaly, itchy patches, often beginning between the toes or on the little finger.
• Drug reactions (exanthematous drug eruption, Stevens‑Johnson syndrome) – Certain medications trigger widespread rashes that can involve the palms and soles.
• Scabies – Mite infestation may produce tiny, intensely itchy papules on the webs of the fingers and on the soles.
• Secondary bacterial infections – Staphylococcus or Streptococcus can cause cellulitis or impetigo with crusted lesions on the hands or feet.
• Contact dermatitis – Direct exposure to irritants (e.g., chemicals, detergents) or allergens (e.g., nickel, latex) can lead to a localized rash.
• Lupus erythematosus (subacute cutaneous lupus) – May present with annular, red plaques on sun‑exposed skin, including the dorsal hands and sometimes the palms.
• COVID‑19‑related rash – Some patients develop acral erythema (often termed “COVID toes”) that can affect the soles and, less commonly, the palms.

Associated Symptoms

The presence of other signs can give clues about the underlying cause:

• Fever, sore throat, or mouth ulcers – suggests hand‑foot‑mouth disease or viral exanthem.
• Itching (pruritus) – common with eczema, scabies, fungal infection, or contact dermatitis.
• Joint pain or swelling – may accompany psoriatic arthritis or reactive arthritis.
• Generalized fatigue, weight loss, night sweats – red flag for systemic infections (e.g., secondary syphilis, HIV).
• Swollen lymph nodes – seen in viral infections and syphilis.
• Blistering or detachment of skin – characteristic of Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Scaling and thickening (hyperkeratosis) – typical of chronic psoriasis or chronic fungal infection.
• Respiratory symptoms (cough, shortness of breath) – can appear with COVID‑19‑related rashes.

When to See a Doctor

Most palm‑ or sole‑rashes are not emergencies, but you should seek medical attention promptly if you experience any of the following:

• Rapid spreading of the rash or sudden appearance of large blisters.
• Severe pain, swelling, or warmth suggesting an infection (cellulitis).
• Fever > 101 °F (38.3 °C) accompanying the rash.
• Difficulty breathing, swallowing, or a feeling of throat tightness.
• Signs of a systemic allergic reaction (hives, swelling of face/lips, dizziness).
• Persistent itching that disrupts sleep or daily activities.
• Known exposure to sexually transmitted infections or a positive pregnancy test combined with a rash.
• Any rash that does not improve within 1–2 weeks of home care.

Diagnosis

Healthcare providers use a step‑wise approach that includes a detailed history, focused physical exam, and targeted tests.

History

• Onset and progression of the rash.
• Recent illnesses, travel, new medications, or exposures to chemicals.
• Sexual history and potential exposure to STIs.
• Family history of psoriasis, eczema, or autoimmune disease.

Physical Examination

• Inspection of distribution (symmetrical vs. unilateral, hands only, feet only).
• Character of lesions – vesicles, papules, plaques, scaling, or pustules.
• Assessment for mucosal involvement, lymphadenopathy, or joint swelling.

Laboratory & Diagnostic Tests

• Skin scraping or biopsy – for fungal hyphae, scabies mites, or histopathology of psoriasis.
• Serologic tests – RPR/VDRL for syphilis, HIV screening, or COVID‑19 PCR/antigen if indicated.
• Blood work – CBC, ESR/CRP to gauge inflammation; liver/kidney panels if drug reaction suspected.
• Patch testing – for suspected allergic contact dermatitis.

Treatment Options

Therapy is directed at the underlying cause and at symptomatic relief. Below is a concise guide:

1. Viral infections (hand‑foot‑mouth disease)

• Supportive care – adequate hydration, analgesics (acetaminophen or ibuprofen).
• Topical anesthetic gels (e.g., lidocaine) for painful mouth sores.
• Rash typically resolves in 7‑10 days without specific antivirals.

2. Psoriasis

• Topical steroids (medium‑potency for short‑term use).
• Vitamin D analogs (calcipotriene) or retinoids.
• Phototherapy (UVB) for extensive disease.
• Systemic agents (methotrexate, biologics) when joints are involved or disease is severe.

3. Secondary syphilis

• Single intramuscular dose of benzathine penicillin G 2.4 MU; alternatives include doxycycline for penicillin‑allergic patients.
• Partner notification and testing are essential.

4. Fungal infections

• Topical antifungals (clotrimazole, terbinafine) for mild tinea.
• Oral terbinafine or itraconazole for extensive or recalcitrant cases (2‑4 weeks).

5. Drug eruptions

• Immediate discontinuation of the suspected medication.
• Oral antihistamines for itching.
• Short course of systemic steroids for severe reactions (under physician supervision).

6. Scabies

• Permethrin 5 % cream applied to the entire body, left for 8‑12 hours, then washed off; repeat in one week.
• Treat close contacts simultaneously.

7. Contact dermatitis

• Avoidance of the offending irritant or allergen.
• Barrier creams (zinc oxide) and low‑potency topical steroids.
• Emollients to restore skin barrier.

8. COVID‑19‑related rash

• Most are self‑limited; treat with gentle skin moisturizers and antihistamines if itchy.
• Follow public‑health guidelines for isolation and monitoring of systemic symptoms.

General symptomatic relief

• Cool compresses to reduce heat and itching.
• Fragrance‑free moisturizers applied several times daily.
• Over‑the‑counter antihistamines (cetirizine, loratadine) for pruritus.
• Avoid scratching to prevent secondary bacterial infection.

Prevention Tips

• Practice good hand‑foot hygiene – wash with mild, fragrance‑free soap and dry thoroughly.
• Wear protective gloves when handling cleaning agents, chemicals, or prolonged water exposure.
• Keep nails trimmed to reduce skin trauma and mite harboring.
• Use antiperspirant powders on feet if excessive sweating contributes to maceration.
• Avoid sharing towels, socks, or shoes with someone who has a known fungal infection.
• Stay up‑to‑date on vaccinations (e.g., measles, varicella) that can cause rashes.
• For sexually active individuals, use condoms and undergo regular STI screening.
• When starting a new medication, ask your provider about common skin side‑effects and report any rash promptly.

Emergency Warning Signs

Key Take‑aways

A rash on the palms or soles can be a harmless, self‑limited condition, but it can also signal systemic infection, autoimmune disease, or a severe drug reaction. Paying attention to accompanying symptoms, timing, and exposure history helps guide appropriate evaluation. While many cases respond to topical therapy and good skin care, persistent, painful, or rapidly evolving lesions warrant prompt medical assessment to rule out serious underlying pathology.

For personalized advice, always consult a healthcare professional. The information above reflects current guidelines from reputable sources such as the Mayo Clinic, CDC, NIH, WHO, and peer‑reviewed dermatology journals (2023‑2024).

```